Patent · US Active

In vivo studies of crystalline forms of meloxicam

US8124603B2 · kind B2 · utility

1Cited by

3References

25Claims

0Family size

Assignee

THAR PHARMACEUTICALS, INC. · US

Inventors

Mazen Hanna · Bradford, GB
Ning Shan · Tampa, US
Miranda L. Cheney · Tampa, US
David R. Weyna · Tampa, US

Key dates

Filing date	Jan 22, 2009
Grant date	Feb 28, 2012
Priority date	—
Expiry date	Apr 1, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to novel crystalline forms of meloxicam. These novel crystalline forms of meloxicam have improved bioavailability, an enhanced rate of dissolution and shorter time to Cmax in blood, as compared to pure meloxicam.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.